IL27 and colorectal carcinoma: Most likely, IL-27 is able to compensate for the lack of T-bet during the process of CTL differentiation by its demonstrated capacity to induce the augmented expression of Eomes [118], representing an alternative T-box transcription factor of described prognostic relevance in the clinical context of CRC [120].